Actinium Pharmaceuticals, Inc. (ATNM)

Net Income

$11.31M

TTM · Period ending: · USD

ATNM logo

ATNM Net Income

Latest reported$11.31M
ATNM TTM Net Income (-$14.80K → $11.31M)
High-resolution chart · PNG

ATNM net income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Actinium Pharmaceuticals, Inc. Net Income — Trailing twelve months (TTM) (USD)
Period endingNet Income (USD)
11,308,000
-23,471,000
-33,887,000
-34,599,000
-41,036,000
-45,511,000
-38,243,000
-40,915,000
-42,623,000
-46,451,000
-48,818,000
-50,141,000
-46,339,000
-38,925,000
-33,017,000
-30,380,000
-27,329,000
-24,583,000
-24,774,000
-23,144,000
-22,261,000
-21,865,000
-22,215,000
-20,437,435
-21,496,435
-21,898,435
-21,898,435
-23,616,000
-23,165,000
-23,001,000
-23,645,000
-22,488,000
-22,663,000
-24,854,000
-26,602,000
-28,135,000
-28,411,000
-27,981,000
-24,322,000
-24,167,000
-21,514,000
-22,354,000
-21,026,000
-19,911,000
-22,042,000
-11,063,000
-24,687,000
-25,141,000
-20,485,000
-26,784,000
-10,774,000
-13,236,000
-14,827,000
-13,606,000
-13,825,909
-5,486,556
-2,478,070
-894,615
10,289
4,414
-1,751
5,965
1,674
699
6,529
-25,314
-22,331
-20,446
-19,927
-25,728
-31,243
-28,268
-31,291
-25,193
-14,800
-18,537
-21,996
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.